J. Groothoff Et Al. , "LUMASIRAN FOR PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 WITH IMPAIRED KIDNEY FUNCTION: DATA FROM THE 6-MONTH ANALYSIS OF THE PHASE 3 ILLUMINATE-C TRIAL," NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37, 2022
Groothoff, J. Et Al. 2022. LUMASIRAN FOR PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 WITH IMPAIRED KIDNEY FUNCTION: DATA FROM THE 6-MONTH ANALYSIS OF THE PHASE 3 ILLUMINATE-C TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37 .
Groothoff, J., Michael, M., Shasha-Lavsky, H., Lieske, J., Frishberg, Y., Simkova, E., ... Sellier-Leclerc, A.(2022). LUMASIRAN FOR PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 WITH IMPAIRED KIDNEY FUNCTION: DATA FROM THE 6-MONTH ANALYSIS OF THE PHASE 3 ILLUMINATE-C TRIAL. NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37.
Groothoff, Jaap Et Al. "LUMASIRAN FOR PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 WITH IMPAIRED KIDNEY FUNCTION: DATA FROM THE 6-MONTH ANALYSIS OF THE PHASE 3 ILLUMINATE-C TRIAL," NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37, 2022
Groothoff, Jaap Et Al. "LUMASIRAN FOR PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 WITH IMPAIRED KIDNEY FUNCTION: DATA FROM THE 6-MONTH ANALYSIS OF THE PHASE 3 ILLUMINATE-C TRIAL." NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37, 2022
Groothoff, J. Et Al. (2022) . "LUMASIRAN FOR PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 WITH IMPAIRED KIDNEY FUNCTION: DATA FROM THE 6-MONTH ANALYSIS OF THE PHASE 3 ILLUMINATE-C TRIAL." NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.37.
@article{article, author={Jaap Groothoff Et Al. }, title={LUMASIRAN FOR PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 WITH IMPAIRED KIDNEY FUNCTION: DATA FROM THE 6-MONTH ANALYSIS OF THE PHASE 3 ILLUMINATE-C TRIAL}, journal={NEPHROLOGY DIALYSIS TRANSPLANTATION}, year=2022}